Hochschulschrift
A toxicogenomic- and pharmacovigilance-based evaluation of drug-induced liver toxicity
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Maße
-
30 cm
- Umfang
-
44, [25] Bl.
- Sprache
-
Englisch
- Anmerkungen
-
Ill., graph. Darst.
Enth. außerdem 2 Sonderabdr. aus: Toxicological sciences ; 112. 2009 und: PLoS one ; Vol. 6. 2011
Hannover, Med. Hochsch., Diss., 2012
- Klassifikation
-
Medizin, Gesundheit
- Urheber
- Inhaltsverzeichnis
- Rechteinformation
-
Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.
- Letzte Aktualisierung
-
11.06.2025, 13:39 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Objekttyp
- Hochschulschrift
Beteiligte
Ähnliche Objekte (12)
Multiscale modeling of drug-induced toxicity in humans
The challenge of drug-induced liver injury (DILI)
Drug-induced neurological disorders
Drug-induced neurological disorders
New approaches to improve prediction of drug-induced liver injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Roussel uclaf causality assessment method for drug-induced liver injury : present and future
Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
Multiscale modeling of drug-induced toxicity in humans
The challenge of drug-induced liver injury (DILI)
Drug-induced neurological disorders
Drug-induced neurological disorders
New approaches to improve prediction of drug-induced liver injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Roussel uclaf causality assessment method for drug-induced liver injury : present and future
Biomarker qualification for drug-induced liver injury across species using immunoaffinity mass spectrometry
Multiscale modeling of drug-induced toxicity in humans
The challenge of drug-induced liver injury (DILI)
Drug-induced neurological disorders
Drug-induced neurological disorders
New approaches to improve prediction of drug-induced liver injury
Charakterisierung der Chemikalien-induzierten Leberschädigung („Drug-Induced Liver Injury“ – DILI)
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Non-canonical BIM-regulated energy metabolism determines drug-induced liver necrosis
Oral cladribine treatment and idiosyncratic drug-induced liver injury in multiple sclerosis
In vitro/ex vivo liver models for the prediction of idiosyncratic drug-induced liver injury
Roussel uclaf causality assessment method for drug-induced liver injury : present and future